Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: 2x 140 mg per day
Total 0 results
Nothing found
Sponsors and Collaborators
Cogniciti
Pia Jaeger, MD, PhD
Hungarian Dental Association
Smart Meter Corporation
UNITI Consortium
Impulse Dynamics, Inc.
The Affiliated Hospital of Xuzhou Medical University
BioNova Pharmaceuticals (Shanghai) LTD.
Université de Genève (UNIGE)
HBSA
Nutrabolt
Vivid Pharma Inc.
NERv Technology Inc
Health Information Technology Solutions (HITS) LLC
Ministry of Public Health, Cameroon
Huisartspraktijk Handellaan
Salena Killion
Shanghai GeneChem Co., Ltd.
Zhongda Hospital, Medical School, Southeast University
Defence Services Medical Academy (DSMA), Myanmar
View Full List
Medical Conditions
Old Age (Focus; Not a Recognized Condition)
VEXAS Syndrome
Advanced Bladder Carcinoma
Immediate Implant Placement
Cerebral Arterial Disease
Alzheimer Disease Focal
Research Mentoring Skills
Cardiovascular Primary Prevention
PET-CT Specimen Imager
Pain, Breakthrough
Biomarkers, Pharmacological
Failed Induction
Infection, Bacterial
Eye Disease, Hereditary
Vertebral Compression Fractures in Osteoporotic Patients
Radiofrequency Ablation Treatment
SMA - Spinal Muscular Atrophy
Premature Rupture of Membranes Prolonged
PPA Syndrome
Endoleaks
View Full List
Drug Interventions
CNTO 6785 50 mg
Olopatadine hydrochloride 0.2%
18F-FDG
OXP005
5 FU continuous
20 mg/kg IV FL-301
HPN328
80% oxygen
Cefadroxil until drain removal
INT-747
TQB2450
Rosuvastatin
0.75% Ropivacaine
Acetylsalicylic acid
Durvalumab + chemotherapy treatment
Lacosamide
Oxymorphone hydrochloride (HCl)
Microneedling with topical glycolic acid 35%.
CJ-12420 200mg + Clarithromycin 500mg
Phase B: Triplixam / Elestar HCT
View Full List
CROs by country
Contract Research Organizations in Angola
Contract Research Organizations in Argentina
Contract Research Organizations in Azerbaijan
Contract Research Organizations in Brazil
Contract Research Organizations in Costa Rica
Contract Research Organizations in Italy
Contract Research Organizations in Jamaica
Contract Research Organizations in Mali
Contract Research Organizations in Nigeria
Contract Research Organizations in Spain
Contract Research Organizations in Taiwan
Contract Research Organizations in Turkmenistan
Contract Research Organizations in Uruguay
CRO list by country
CROs in Nigeria
54gene’s Clinical Programs Group (CPG)
ACROSS Global
SGS
Celero
Bispharm Clinical
All CROs in Nigeria
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe